HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
Provided By GlobeNewswire
Last update: Nov 14, 2025
MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2025.
Read more at globenewswire.com
